PFE trades at just 8x forward earnings while paying a near-7% dividend yield, and the five-year base case model targets $49. Pfizer's Berobenatide GLP-1 posted 16% weight loss at 32 weeks with no ...
June 15 - Global drugmakers are expanding their U.S. footprint, pledging billions of dollars to ramp up manufacturing capacity and research in the country. Pharmaceutical companies including Eli Lilly ...
The Trump administration’s dramatic reworking of U.S. public-health agencies’ approach to vaccines is creating a difficult and unpredictable situation for drugmakers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results